US Stock MarketDetailed Quotes

ESLA Estrella Immunopharma

Watchlist
  • 0.8800
  • -0.0600-6.38%
Close Apr 4 16:00 ET
  • 0.8800
  • 0.00000.00%
Post 16:05 ET
31.83MMarket Cap-3.61P/E (TTM)

Estrella Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q1)Sep 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-60.17%4.43M
80.53%3.38M
44.59%3.95M
-82.87%469.53K
-62.97%1.02M
-35.17%1.87M
559.47%11.11M
154.29%2.73M
1,528.78%2.74M
2,502.95%2.76M
Selling and administrative expenses
136.49%1.57M
-60.29%550.74K
172.56%424.45K
277.66%444.53K
536.85%945.17K
394.92%1.39M
123.86%663.19K
382.74%155.73K
745.08%117.71K
358.08%148.41K
-General and administrative expense
136.49%1.57M
-60.29%550.74K
172.56%424.45K
277.66%444.53K
536.85%945.17K
394.92%1.39M
123.86%663.19K
382.74%155.73K
745.08%117.71K
358.08%148.41K
Research and development costs
-72.65%2.86M
484.53%2.83M
36.85%3.53M
-99.05%25K
-97.11%75.46K
-81.44%483.47K
652.37%10.45M
147.22%2.58M
1,306.35%2.62M
3,448.49%2.61M
Operating profit
60.17%-4.43M
-80.53%-3.38M
-44.59%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Net non-operating interest income expense
Other net income (expense)
Income before tax
60.17%-4.43M
-80.53%-3.38M
-44.59%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Income tax
63
0
1.63K
0
0
0
0
0
0
0
Net income
60.17%-4.43M
-80.53%-3.38M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Net income continuous Operations
60.17%-4.43M
-80.53%-3.38M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Minority interest income
Net income attributable to the parent company
60.17%-4.43M
-80.53%-3.38M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
60.17%-4.43M
-80.53%-3.38M
-44.65%-3.95M
82.87%-469.53K
62.97%-1.02M
35.17%-1.87M
-559.47%-11.11M
-154.29%-2.73M
-1,528.78%-2.74M
-2,502.95%-2.76M
Basic earnings per share
61.99%-0.12
-69.37%-0.09
-67.53%-0.13
87.16%-0.01
61.69%-0.03
35.18%-0.0531
-559.47%-0.3157
-154.29%-0.0776
-1,528.74%-0.0779
-2,503.13%-0.0783
Diluted earnings per share
61.99%-0.12
-69.37%-0.09
-67.53%-0.13
87.16%-0.01
61.69%-0.03
35.18%-0.0531
-559.47%-0.3157
-154.29%-0.0776
-1,528.74%-0.0779
-2,503.13%-0.0783
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(FY)Dec 31, 2024(Q1)Sep 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -60.17%4.43M80.53%3.38M44.59%3.95M-82.87%469.53K-62.97%1.02M-35.17%1.87M559.47%11.11M154.29%2.73M1,528.78%2.74M2,502.95%2.76M
Selling and administrative expenses 136.49%1.57M-60.29%550.74K172.56%424.45K277.66%444.53K536.85%945.17K394.92%1.39M123.86%663.19K382.74%155.73K745.08%117.71K358.08%148.41K
-General and administrative expense 136.49%1.57M-60.29%550.74K172.56%424.45K277.66%444.53K536.85%945.17K394.92%1.39M123.86%663.19K382.74%155.73K745.08%117.71K358.08%148.41K
Research and development costs -72.65%2.86M484.53%2.83M36.85%3.53M-99.05%25K-97.11%75.46K-81.44%483.47K652.37%10.45M147.22%2.58M1,306.35%2.62M3,448.49%2.61M
Operating profit 60.17%-4.43M-80.53%-3.38M-44.59%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Net non-operating interest income expense
Other net income (expense)
Income before tax 60.17%-4.43M-80.53%-3.38M-44.59%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Income tax 6301.63K0000000
Net income 60.17%-4.43M-80.53%-3.38M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Net income continuous Operations 60.17%-4.43M-80.53%-3.38M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Minority interest income
Net income attributable to the parent company 60.17%-4.43M-80.53%-3.38M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 60.17%-4.43M-80.53%-3.38M-44.65%-3.95M82.87%-469.53K62.97%-1.02M35.17%-1.87M-559.47%-11.11M-154.29%-2.73M-1,528.78%-2.74M-2,502.95%-2.76M
Basic earnings per share 61.99%-0.12-69.37%-0.09-67.53%-0.1387.16%-0.0161.69%-0.0335.18%-0.0531-559.47%-0.3157-154.29%-0.0776-1,528.74%-0.0779-2,503.13%-0.0783
Diluted earnings per share 61.99%-0.12-69.37%-0.09-67.53%-0.1387.16%-0.0161.69%-0.0335.18%-0.0531-559.47%-0.3157-154.29%-0.0776-1,528.74%-0.0779-2,503.13%-0.0783
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Sample Name
Sample Code
 +29.98%
Sample Name
Sample Code
 +29.93%
Sample Name
Sample Code
 +20.30%
4
Shanghai Menon Animal Nutrition Technology
301156
+20.03%
5
Nanjing Railway New Technology
301016
+20.02%
Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 127.870
Sample Name
Sample Code
 293.610
Sample Name
Sample Code
 69.140
4
KB Home
KBH
57.540
5
Taylor Morrison Home
TMHC
59.420
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 605.550
Sample Name
Sample Code
 147.740
Sample Name
Sample Code
 145.600
4
Microsoft
MSFT
359.840
5
Amazon
AMZN
171.000
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 2.015
Sample Name
Sample Code
 11.300
Sample Name
Sample Code
 0.3345
4
CleanSpark
CLSK
7.320
5
IREN Ltd
IREN
5.940
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -